tiagabine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, X; Fei, J; Huang, D; Huang, F; Huang, L; Liu, J; Ma, Y; Suo, H; Tong, J; Wang, P; Wang, Z; Xu, J; Yang, Y; Yu, M | 1 |
1 other study(ies) available for tiagabine and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation.
Topics: Animals; Baclofen; Cell Line, Tumor; Disease Models, Animal; Dopaminergic Neurons; GABA Plasma Membrane Transport Proteins; Inflammation Mediators; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; MPTP Poisoning; Muscimol; Neuroprotective Agents; Neurotoxins; NF-kappa B; Nipecotic Acids; Tiagabine | 2015 |